Producing world-class research to improve the quality, productivity, and fairness of the US health system.
The US spends $4.3 trillion annually on health care - 18.3% of US GDP- creating an enormous strain on American families and the economy. Despite this significant investment, our country isn’t getting healthier, quality healthcare is unaffordable, and the healthcare system isn’t operating as efficiently or productively as it could.
Our Health Economics portfolio considers how the health system and the American economy impact each other, across the range of major players: private insurance, public (Medicare and Medicaid), and supplementary insurance systems that bridge the gap. In addition, we played a meaningful role in the national response to COVID-19, created a new national resource reducing risk in nursing homes featured by CDC and AARP, and launched the 1 Percent Steps for Health Care Reform project, a new multi-university initiative to reframe the debate on health care.
Policy Brief: A Review of the Academic and Expert Literature on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
